Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Non-cash Items (2016)

Viridian Therapeutics, Inc.\DE (VRDN) has 3 years of Non-cash Items data on record, last reported at $37465.0 in Q4 2016.

  • For Q4 2016, Non-cash Items fell 51.97% year-over-year to $37465.0; the TTM value through Dec 2016 reached $37465.0, down 51.97%, while the annual FY2016 figure was $37465.0, 51.97% down from the prior year.
  • Non-cash Items reached $37465.0 in Q4 2016 per VRDN's latest filing, down from $262194.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $407000.0 in Q1 2015 and bottomed at $2000.0 in Q2 2015.
  • Average Non-cash Items over 3 years is $167293.2, with a median of $132378.0 recorded in 2016.
  • Peak YoY movement for Non-cash Items: crashed 80.1% in 2015, then surged 7339.9% in 2016.
  • A 3-year view of Non-cash Items shows it stood at $392000.0 in 2014, then plummeted by 80.1% to $78009.0 in 2015, then plummeted by 51.97% to $37465.0 in 2016.
  • Per Business Quant database, its latest 3 readings for Non-cash Items were $37465.0 in Q4 2016, $262194.0 in Q3 2016, and $148798.0 in Q2 2016.